These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 8254032

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals.
    Tessitore L, Costelli P, Bonetti G, Baccino FM.
    Arch Biochem Biophys; 1993 Oct; 306(1):52-8. PubMed ID: 8215420
    [Abstract] [Full Text] [Related]

  • 3. Humoral mediation for cachexia in tumour-bearing rats.
    Tessitore L, Costelli P, Baccino FM.
    Br J Cancer; 1993 Jan; 67(1):15-23. PubMed ID: 8427775
    [Abstract] [Full Text] [Related]

  • 4. Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats.
    Llovera M, López-Soriano FJ, Argilés JM.
    J Natl Cancer Inst; 1993 Aug 18; 85(16):1334-9. PubMed ID: 8340946
    [Abstract] [Full Text] [Related]

  • 5. Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
    Dessì S, Batetta B, Spano O, Bagby GJ, Tessitore L, Costelli P, Baccino FM, Pani P, Argilès JM.
    Br J Cancer; 1995 Nov 18; 72(5):1138-43. PubMed ID: 7577459
    [Abstract] [Full Text] [Related]

  • 6. Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model.
    Carbó N, Costelli P, Tessitore L, Bagby GJ, López-Soriano FJ, Baccino FM, Argilés JM.
    Clin Sci (Lond); 1994 Sep 18; 87(3):349-55. PubMed ID: 7955912
    [Abstract] [Full Text] [Related]

  • 7. Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.
    Costelli P, García-Martínez C, Llovera M, Carbó N, López-Soriano FJ, Agell N, Tessitore L, Baccino FM, Argilés JM.
    J Clin Invest; 1995 May 18; 95(5):2367-72. PubMed ID: 7738199
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cancer cachexia results in an increase in TNF-alpha receptor gene expression in both skeletal muscle and adipose tissue.
    Figueras M, Busquets S, Carbó N, Almendro V, Argilés JM, López-Soriano FJ.
    Int J Oncol; 2005 Sep 18; 27(3):855-60. PubMed ID: 16077938
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alterations in whole body, muscle, liver, and tumor tissue protein synthesis and degradation in Novikoff hepatoma and Yoshida sarcoma tumor growth studied in vivo.
    Tayek JA, Blackburn GL, Bistrian BR.
    Cancer Res; 1988 Mar 15; 48(6):1554-8. PubMed ID: 3345528
    [Abstract] [Full Text] [Related]

  • 13. Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486.
    Llovera M, García-Martínez C, Costelli P, Agell N, Carbó N, López-Soriano FJ, Argilés JM.
    Cancer Lett; 1996 Jan 19; 99(1):7-14. PubMed ID: 8564931
    [Abstract] [Full Text] [Related]

  • 14. Liver and skeletal muscle protein metabolism in Yoshida ascites hepatoma AH-130-bearing rats.
    Tessitore L, Bonelli G, Rubano R, Terzuolo S, Baccino FM.
    Prog Clin Biol Res; 1985 Jan 19; 180():599-601. PubMed ID: 4034563
    [No Abstract] [Full Text] [Related]

  • 15. Anabolic deficits and divergent unfolded protein response underlie skeletal and cardiac muscle growth impairments in the Yoshida hepatoma tumor model of cancer cachexia.
    Belcher DJ, Kim N, Navarro-Llinas B, Möller M, López-Soriano FJ, Busquets S, Nader GA.
    Physiol Rep; 2024 Sep 19; 12(18):e70044. PubMed ID: 39294861
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth.
    Costelli P, Llovera M, López-Soriano J, Carbó N, Tessitore L, López-Soriano FJ, Baccino FM, Argilés JM.
    Cancer Lett; 1995 Oct 20; 97(1):25-32. PubMed ID: 7585474
    [Abstract] [Full Text] [Related]

  • 19. Protein turnover states of tumour cells and host tissues in an experimental model.
    Baccino FM, Tessitore L, Bonelli G, Isidoro C.
    Biomed Biochim Acta; 1986 Oct 20; 45(11-12):1585-90. PubMed ID: 3579877
    [Abstract] [Full Text] [Related]

  • 20. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
    Gelin J, Moldawer LL, Lönnroth C, Sherry B, Chizzonite R, Lundholm K.
    Cancer Res; 1991 Jan 01; 51(1):415-21. PubMed ID: 1703040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.